Effects of a stepped-care intervention programme among older subjects who screened positive for depressive symptoms in general practice: the PROMODE randomised controlled trial by Weele, G.M. van der et al.
Age and Ageing 2012; 41: 482–488
doi: 10.1093/ageing/afs027
© The Author 2012. Published by Oxford University Press on behalf of the British Geriatrics Society.
All rights reserved. For Permissions, please email: journals.permissions@oup.com
Published electronically 16 March 2012
Effects of a stepped-care intervention
programme among older subjects who
screened positive for depressive symptoms in
general practice: the PROMODE randomised
controlled trial
GERDA M. VAN DER WEELE1, MARGOT W. M. DE WAAL1, WILBERT B. VAN DEN HOUT2, ANTON J. M. DE
CRAEN3, PHILIP SPINHOVEN4, THEO STIJNEN5, WILLEM J. J. ASSENDELFT1, ROOS C. VAN DER MAST4,
JACOBIJN GUSSEKLOO1
1Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands
2Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands
3Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands
4Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands
5Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands
Address correspondence to: Margot W. M. de Waal. Email: M.W.M.de_Waal@lumc.nl
Abstract
Objectives: to determine (cost)-effectiveness of a stepped-care intervention programme among subjects ≥75 years who
screened positive for depressive symptoms in general practice.
Design: the pragmatic cluster-randomised controlled trial with 12-month follow-up.
Setting: sixty-seven Dutch general practices.
Subjects: two hundred and thirty-nine subjects ≥75 years screened positive for untreated depressive symptoms (15-item
Geriatric Depression Scale ≥5).
Methods: usual care (34 practices, 118 subjects) was compared with the stepped-care intervention (33 practices, 121 sub-
jects) consisting of three steps: individual counselling; Coping with Depression course; and—if indicated—referral back to
general practitioner to discuss further treatment. Measurements included severity of depressive symptoms [Montgomery-
Åsberg Depression Rating Scale (MADRS)], quality of life, mortality and costs.
Results: at baseline subjects mostly were mildly/moderately depressed. At 6 months MADRS scores had improved more
in the usual care than the intervention group (−2.9 versus −1.1 points, P = 0.032), but not at 12 months (−3.1 versus −4.6,
P = 0.084). No significant differences were found within two separate age groups (75–79 years and ≥80 years). In interven-
tion practices, 83% accepted referral to the stepped-care programme, and 19% accepted course participation. The control
group appeared to have received more psychological care.
Conclusions: among older subjects who screened positive for depressive symptoms, an offered stepped-care intervention
programme was not (cost)-effective compared with usual care, possibly due to a low uptake of the course offer.
Trial registration: www.controlled-trials.com/ISRCTN 71142851v.
















Depressive symptoms at old age have a negative impact on well-
being [1, 2], quality of life [3], daily functioning and mortality [4],
and increase the risk of developing major depression [5]. At old
age depressive symptoms are reported to be under-recognised
and undertreated [6], although psychological interventions have
shown positive effects on clinical outcomes [7, 8].
Therefore, screening older subjects for depressive symp-
toms, followed by effective treatment of screen-positive
subjects, is advocated [6]. Two large randomised controlled
trials (RCTs) in the USA evaluated the (cost)-effectiveness
of care management programmes for depressed subjects
≥60 years, who were (partly) detected by screening, and
showed reduced suicidal ideation [9], reduced depressive
symptoms [10] and cost-effectiveness [11]. However, it is
unknown whether screening for depressive symptoms fol-
lowed by an intervention offer is beneficial and cost-
effective for the oldest old. Therefore, the PROMODE
study (Proactive Management of Depression in the Elderly)
was initiated. PROMODE consisted of a screening study
[12] and a subsequent pragmatic RCT offering either a
stepped-care intervention or usual care.
The aim of the present study was to investigate the
effects and costs of the stepped-care intervention offered
to subjects ≥75 years who were screened positive for un-
treated depressive symptoms, compared with usual care.
Subjects aged 75–79 years and ≥80 years were also exam-
ined separately, to reveal possible age-dependent differences
in the effect of this programme.
Methods
Study procedures and population
From April 2007 until July 2008, in 67 general practices in
the Leiden region (the Netherlands) all 11,635 registered
subjects aged ≥75 years were invited for screening at home
for depressive symptoms. Exclusion criteria were current
treatment for depression, clinical diagnosis of dementia or
a Mini-Mental State Examination (MMSE) score <19
points, loss of partner or child in the preceding 3 months,
life expectancy ≤3 months and not speaking Dutch.
Screening procedures have been described previously [12].
Screening yielded 264 screen-positive subjects according
to a ≥5 points score on an interviewer-administered
15-item version of the Geriatric Depression Scale (GDS-15)
[13]. Of those, 239 subjects gave written informed consent
to participate in the randomised trial.
The Medical Ethical Committee of the Leiden
University Medical Center approved the study.
Intervention and usual care
General practitioners (GPs) in intervention practices were
instructed to inform screen-positive subjects about screen-
ing result and to motivate them for referral to the
community mental health centre. The subsequent stepped-
care intervention consisted of: step 1—individual counsel-
ling concerning treatment needs and motivation of the sub-
jects during one or two home visits by a community
psychiatric nurse; step 2—coping with Depression course
by trained mental health professionals; if indicated (irre-
spective of course participation), step 3—referral back to
GP to discuss further treatment.
The ‘Coping with Depression’ course, based on cognitive
behavioural therapy, is effective in treating older subjects
with depressive symptoms [14]. It consists of 10 weekly
group meetings, with 2 course instructors and about 6–10
participants. If subjects were willing to accept the course
offer, but had problems with attending group sessions, the
course was offered on an individual basis at their home.
To ensure usual care, GPs in control practices were not
informed about screen-positive subjects in their practice
before the end of the study. Only in case of severe depressive
symptoms [Montgomery-Åsberg Depression Rating Scale
(MADRS)] score >30 points, see section ‘Measurements’)
and/or suicidal ideation was the GP contacted by the
researcher. Patients in the control practices were not indi-
vidually informed about being screen-positive and treatment
allocation.
Randomisation and blinding
A cluster randomised design, with the general practice as
unit of randomisation, was chosen to prevent contamination
[15]. After completion of screening and baseline assess-
ment, block randomisation was performed using opaque
envelopes. Research nurses were not informed about prac-
tice allocation.
Measurements
The GDS-15 was used as a screening tool for depression.
To measure cognitive functioning the MMSE was used
[16]. Subjects with an MMSE score <19 points were
excluded because of reduced reliability and validity to fill
out the other questionnaires.
The primary outcome measure was change in severity of
depressive symptoms between study groups after 6 months
as assessed with the MADRS [17]. The MADRS scale con-
sists of 10 items representing the depression core symp-
toms. For each item, scores range from 0 to 6 points, with
higher scores indicating more serious depression. Training
of nurses occurred on a regular basis, with special attention
paid to administering and scoring the MADRS in a
uniform way. Therefore, the MADRS part of the interviews
was videotaped; all MADRS scales were scored by both the
interviewer and another research nurse and consensus
scores were used in the analyses.
Secondary outcome measures were change in the
MADRS score between study groups after 12 months; per-
centage responders to treatment (intervention or usual
care) defined as ≥50% decrease in the MADRS score
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compared with baseline at 6 and 12 months; quality of life,
mortality and costs. For further measurements see
Supplementary data, available in Age and Ageing online,
Appendices 1 and 3.
Follow-up
At 6 and 12 months after baseline measurements, subjects
were visited at home to assess the GDS-15, MADRS,
SF-36, chronic pain and MMSE (only at 12 months).
Sample size calculation
It was assumed that each cluster would provide 3 screen-
positive subjects, on an average 1.5 subjects per age group.
We planned to include 33 clusters per study arm to detect a
clinically relevant difference in the MADRS score of at
least 6 points in each age group (assumptions: SD = 10
points; power 80%; α = 0.05; intracluster correlation coeffi-
cient (ICC) = 0.2). The (unknown) ICC was chosen conser-
vatively to ascertain sufficient power [18].
Statistical analysis
Analyses were performed for all subjects and for both age
groups separately. MADRS score changes after 6 and 12
months were analysed according to an intention-to-treat
basis.
First, we analysed outcomes on the subject level.
Sensitivity analyses were performed by substituting missing
MADRS score data at 6 and 12 months following three
methods: (i) last-observation-carried-forward (LOCF), (ii)
highest MADRS scores in our study (30 points at 6
months and 29 points at 12 months) and (iii) lowest
MADRS score in our study (0 points at 6 and 12 months).
Second, MADRS data were analysed using linear mixed
models (LMM) to account for clustering at the practice
level, with adjustment for MADRS scores at baseline, age
and gender. Finally, measurements at 12 months were also
included in the model to analyse the long-term effect.
To check whether subgroups benefited from the inter-
vention on the longer term, stratified analyses were per-
formed using LMM with the outcome. MADRS score
changes at 12 months dependent on the presence of
DSM-IV depressive disorder, perceived loneliness, chronic
diseases, treatment per protocol and baseline MADRS
score >10 points.
Hazard ratios (HRs) for death were estimated using a
Cox proportional hazards model. Statistical analyses were
carried out using SPSS 16.0 for Windows.
Results
Study population
After baseline measurements, 33 practices with 121 subjects
were randomly allocated to the intervention arm and 34
practices with 118 subjects to the control arm (Figure 1).
The researcher contacted the GP for three subjects in
control practices and for two subjects in intervention prac-
tices because of an MADRS score >30 points and/or sui-
cidal ideation. In the intervention group 7 subjects died, 10
subjects refused follow-up visits at 6 and/or 12 months
and 3 subjects were unable to reliably answer the questions
at 12 months. In the control group, 17 subjects died (includ-
ing one subject who committed suicide, with an MADRS
score <30 points and no suicidal ideation at baseline), 6 sub-
jects refused follow-up visits at 6 and/or 12 months and 2
subjects had become incompetent at 12 months. As a result,
210 subjects could be analysed at 6 months (107 interven-
tion and 103 control subjects), and 194 subjects at 12
months (101 intervention and 93 control subjects).
Table 1 presents the demographic and clinical character-
istics at baseline. Baseline characteristics between groups
were similar. Median MADRS scores indicated that subjects
mostly were mildly/moderately depressed.
Intervention uptake
In the intervention practices, 101 of all 121 screen-positive
subjects (83%) accepted referral to the community mental
health centre to start with the stepped-care intervention.
Course participation was accepted by 23 (19%) subjects.
Most of them (70%) finished the course. Additionally, two
subjects followed the course on an individual basis and 21
participated in a group course. Five other subjects (4%)
started another type of treatment.
Severity of depressive symptoms during follow-up
In the intervention group, median GDS scores remained
stable at 6 points during follow-up; in the control group,
scores decreased from 7 to 5. During follow-up, there was
an overall decrease in MADRS scores, meaning an im-
provement in severity of depressive symptoms. After 6
months, this decrease was significantly stronger in the
control group than in the intervention group, but not after
12 months (Table 2). Sensitivity analyses, after substitution
of missing data by LOCF or by the highest or lowest
MADRS scores in our study population, did not substan-
tially change these results (data not shown).
Taking clustering of subjects into account, and control-
ling for the baseline MADRS score, age and gender, the de-
crease in the MADRS score after 6 months was 1.4 points
less in the intervention group than in the control group
(P= 0.056, ICC = 0). Including measurements at 12 months,
MADRS scores in the intervention group tended to be
higher at all measurement moments (P= 0.088, ICC =
0.045). In none of the analysed subgroups was a positive
intervention effect observed (data not shown).
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A total of 24 subjects died during follow-up, 7 (5.8%) in
the intervention group and 17 (14.4%) in the control group
(HR: 2.7; 95% CI: 1.1–6.5, adjusted for age and gender).
After further adjustment for the baseline MADRS score
and co-morbidity (CIRS-total score), the HR was 2.3 (95%
CI: 0.94–5.6).
Age-stratified results
Between subjects aged 75–79 years and ≥80 years no dif-
ferences were found in course participation and finishing
the course. In both age groups, the intervention showed
no positive effects on any of the MADRS outcomes or
mortality (Supplementary data are available in Age and
Ageing online, Appendix 2).
Economic evaluation
Costs of the stepped-care intervention were estimated at
€333 per referral to the stepped-care programme (n= 101).
No significant differences were found in other costs or
quality of life (Supplementary data are available in Age and
Ageing online, Appendix 3).
Discussion
The present study shows no beneficial effect regarding se-
verity of depressive symptoms of a stepped-care interven-
tion programme among subjects aged ≥75 years who
screened positive for untreated depressive symptoms, which
mostly were mild to moderate, in general practice. Without
beneficial effect, also the cost-effectiveness of the pro-
gramme is unfavourable.
Figure 1. Flow chart of the PROMODE intervention study giving numbers of study subjects per age group between brackets
(75–79 years in italics; 80 years and over not italicised).
485














These negative findings are in contrast with the mainly
positive reviews reporting that screening or case finding
with subsequent enhanced care is effective in decreasing
symptoms of depression [19–21], albeit sometimes
marginally [22]. However, compared with the present study,
most studies included in these reviews targeted their inter-
vention at populations with more (serious) depressive
symptoms and/or were performed in younger populations
(mostly over 55 or over 60 years). Furthermore, studied
interventions are heterogeneous and ‘usual care’ may have
relevant cross-cultural differences. In the Dutch healthcare
system, GPs are the primary caregivers for all community-
living subjects and often have a longstanding and close rela-
tionship with their registered (older) patients. This enables a
continuity of care that probably resembles the idea of a
‘personal care manager’, a seemingly important factor in
successful interventions such as IMPACT [9]. Our aim was
to enhance primary care in the intervention arm. However,
we suspect the marginal role of the GP gave a breach in
continuity of care that was not beneficial. In a recent Dutch
trial stepped-care significantly reduced the risk of develop-
ing a major depressive or anxiety disorder. Although com-
parable with our study regarding healthcare setting and the
age group, they included persons with persistent depressive
symptoms and added problem-solving treatment to their
intervention [8]. Our negative results are in line with a
recent meta-analysis that concluded that psychological treat-
ment for depressive symptoms is effective in primary care,
but only when patients were referred by their GP for treat-
ment and not when they were detected by screening [23].
Our study has some major strengths. Firstly, we did not
only focus on older persons with major depression and/or
dysthymia, but we focused on subjects who screened posi-
tive for clinically relevant depressive symptoms, which
represents the full spectrum of depression seen in general
practice. This is especially important at old age, given the
relatively high prevalence of subthreshold and minor de-
pression, thereby enhancing the generalisability of our
results in general practice. For the same reason, we chose a
pragmatic study design, not strongly regulating the process
of the intervention carried out by mental healthcare [24].
Secondly, our study was powered to investigate effects in
two separate age groups, 75–79 years and ≥80 years.
Mortality risk was higher in the control group than in the
intervention group (if the age groups are combined) but
not in the age-stratified groups, suggesting that our study
may have been underpowered to draw definite conclusions
per age group for mortality.
A possible limitation of the present study is that we
chose a change in the MADRS score as our primary
outcome measure. Although the MADRS is frequently
used and validated to measure (changes in) severity of de-
pressive symptoms among older subjects with moderate to
severe depression, it may not be the optimal instrument to
measure change in relatively mild depressive symptoms, and
is not validated as such. Furthermore, our study could not
be blinded and control subjects could have been triggered
to seek help. This attention bias [25] may have played a role
in our study, since the control group appeared to have
received more psychological care than the intervention
group. Also, the research nurses could not be completely
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. MADRS outcomes at 6 months and 12 months in






MADRS scores at 6 months
Subjects, n 107 103
MADRS score, median (IQR) 12 (7–16) 11 (6–15) 0.22
MADRS responders, n (%) 17 (16) 23 (22) 0.24
MADRS change compared with
baseline, mean (SEM)
−1.1 (0.61) −2.9 (0.58) 0.032
MADRS scores at 12 months
Subjects, n 101 93
MADRS score, median (IQR) 10 (6–14) 10 (5–13) 0.45
MADRS responders, n (%) 21 (21) 31 (33) 0.049
MADRS change compared with
baseline, mean (SEM)
−3.1 (0.61) −4.6 (0.64) 0.084
MADRS, Montgomery-Åsberg Depression Rating Scale; IQR, inter-quartile
range; SEM, standard error of the mean; Responder, subject with MADRS
score decrease ≥50% compared with baseline.
Continuous data are compared with the Mann–Whitney U test, categorical data
with the Chi-square test, and changes of means with independent samples
t-test.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .






Age in years 80 (77–84) 80 (77–84)
Female sex 85 (70) 88 (75)
Income social security only 17 (14) 23 (20)
Living alone 76 (63) 78 (66)
Living independently 86 (71) 85 (72)
Clinical characteristics
Perceived loneliness present 81 (67) 83 (70)
Alcohol intake >14 drinks/week 10 (8) 13 (11)
Chronic pain present 81 (67) 80 (68)
Somatic co-morbidity (CIRS-TSC) 13 (9–16) 13 (10–17)
SF-36 Physical component score 45 (38–52) 44 (38–53)
SF-36 Mental component score 46 (40–52) 46 (40–51)
Neuropsychiatric characteristics
MADRS score 12 (8–18) 14 (11–17)
GDS-15 score 6 (5–8) 7 (6–9)
DSM-IV diagnosis present 52 (43) 53 (45)
Major depression present 17 (14) 19 (16)
Minor depression present 16 (13) 12 (10)
Dysthymia present 19 (16) 22 (19)
HADS-A score 5 (3–6) 5 (3–8)
MMSE score 28 (26–29) 28 (26–29)
Data are presented as numbers and percentages or medians and inter-quartile
ranges.
CIRS-TSC, cumulative illness rating scale total score; MADRS,
Montgomery-Åsberg Depression Rating Scale; GDS-15, Geriatric Depression
Scale 15-items version; DSM-IV, Diagnostic and Statistical Manual of Mental
Disorders (4th edition); HADS-A, Hospital Anxiety Depression Scale,
anxiety-subscale; MMSE, Mini-Mental State Examination; SF-36, Short-Form
36 items.
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blinded for treatment allocation during follow-up visits, al-
though they were not informed about this by the research
team. To avoid a biased assessment and scoring of the
MADRS, permanent training for the research nurses was
provided and all videotaped MADRS interviews were inde-
pendently scored. Finally, we were only partially informed
about the third step of the intervention, in spite of our
attempts to get complete and reliable information.
Our study shows a low uptake (19%) of the course
offer among screen-positive older subjects, which probably
is not surprising since these subjects did not (have the in-
tention to) ask for help. In a qualitative exploration, we
found that important reasons for declining the course offer
were: not feeling depressed, or having negative thoughts
about the course effect, about group participation or about
being too old to change and learn new things [26]. Being
screen-positive requires further exploration of subjective
complaints and needs, as well as the motivation to accept
help. Moreover, particularly in old age, it seems important
that exploration of needs should not only focus on the de-
pressive symptoms but also on other domains, such as
functional limitations and chronic pain. Such an exploration
will probably require a longitudinal approach with several
stages and a broad scope with respect to possible interven-
tion options. Furthermore, in the present study the GPs
(who are a respected and trusted advisor for most elderly
subjects) were allocated only a limited role, because we
assumed that they could not invest the extra time required
for the follow-up of screen-positive subjects. It is an im-
portant question whether an intervention programme
would have been more successful if the GP had been more
involved in exploring their patients’ needs after screening.
In conclusion, among older subjects who screened posi-
tive for depressive symptoms in general practice the offer
of a stepped-care intervention did not result in better clinic-
al outcomes compared with usual care. Possibly, this was
partly due to the low uptake of the main part of the inter-
vention. Therefore, this combined screening/stepped-care
intervention programme for depressive symptoms does not
seem to be a useful strategy to deal with untreated depres-
sive symptoms at old age. It seems worthwhile to explore
whether a more individualised approach for screen-positive
subjects would yield more effective results.
Key points
• The stepped-care intervention programme for screen-
positive depressed subjects aged 75 years and over did
not result in better clinical outcomes compared with usual
care.
• Among screen-positive subjects the uptake of the main
part of the intervention was only 19%.
• Economic evaluation of the stepped-care intervention
programme also showed no favourable results.
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